Promotes transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Would promote transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Sets controls on Medicaid prescription drug costs by imposing transparency and accountability requirements on managed care organizations (MCOs) and their pharmacy benefit managers (PBMs).
Provides a civil cause of action for individuals injured by artificial intelligence.
Provides a civil cause of action for individuals injured by artificial intelligence.
Requires DOA provide inventory of all state agencies using artificial intelligence (AI); establishes a 13 member permanent commission to monitor the use of AI in state government and makes recommendations for state government policy and other decisions.
Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.